Associate Software Engineer
Globus Medical4 months ago
Audubon, PA, USAEntry Level / Mid Level
Responsibilities
- Design and develop software modules and components for medical devices.
- Deploy, maintain, and update full-stack medical-device applications across platforms.
- Test, debug, and troubleshoot applications in cadaveric and laboratory settings.
- Contribute to validation testing, execute design-verification procedures, and assist validation activities.
- Manage assigned tasks, documentation, version control, toolchain requirements, and quality-system compliance.
- Attend surgical cases periodically to understand clinical context and end-user requirements.
Requirements
- Bachelor’s degree with 0–3 years of professional programming experience or a master’s degree.
- Object-oriented C++ development experience, including C++17 and later.
- Experience with or willingness to learn Qt and QML.
- Experience with or willingness to learn Visual Studio, Visual Studio Code, and Git.
- Working knowledge of Windows, Microsoft Teams, and Microsoft Office.
- Strong problem-solving, communication, organization, teamwork, and independent-working skills.
- Medical-device or life-science experience and test-driven development experience are assets.
- Ability to travel up to 5% and attend cadaver laboratories and surgeries in the United States.
Benefits
- On-site work arrangement.
- Up to 5% travel within the United States, including attendance at cadaver laboratories and surgeries.
- Equal opportunity employer committed to an inclusive and respectful workplace.
Categories
About Globus Medical
Globus Medical builds musculoskeletal medical devices, including spinal and orthopedic trauma implants, biomaterials, and enabling technologies such as the ExcelsiusGPS robotic navigation system, sold to hospitals and surgeons. The company generates revenue through the sale of implants, instruments, and related software and services used in surgery. Founded in 2003 and headquartered in Audubon, Pennsylvania, it is publicly traded on the NYSE (GMED) and in 2023 combined with NuVasive to expand its spine portfolio.